Sichenzia Ross Ference Kesner LLP Represents Medovex Corp. in Registered Direct Offering
Press Release — New York, NY — August 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented Medovex Corp. (NASDAQ:MDVX), a medical products manufacturer, in a registered direct offering of units consisting of 2,956,046 shares of common stock and 1,478,023 warrants to purchase common stock at a price of $0.91 per unit resulting in gross proceeds of $2,680,000.
The Sichenzia Ross Ference Kesner LLP team was led by partners Harvey Kesner and Arthur Marcus.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- 加州新商业融资披露立法 - September 28, 2018
- Sichenzia Ross Ference LLP宣布推出新的Web域名 - September 26, 2018
- Sichenzia Ross Ference LLP Represents AIT Therapeutics, Inc. in $20,000,000 Line of Credit - September 6, 2018